NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 1,056.00
-43.10 (-3.92%)
At close: Apr 21, 2026
NATCO Pharma Revenue
NATCO Pharma had revenue of 6.47B INR in the quarter ending December 31, 2025, with 36.33% growth. This brings the company's revenue in the last twelve months to 45.63B, up 6.60% year-over-year. In the fiscal year ending March 31, 2025, NATCO Pharma had annual revenue of 44.32B with 10.74% growth.
Revenue (ttm)
45.63B
Revenue Growth
+6.60%
P/S Ratio
4.14
Revenue / Employee
10.87M
Employees
4,199
Market Cap
189.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 44.32B | 4.30B | 10.74% |
| Mar 31, 2024 | 40.02B | 12.94B | 47.76% |
| Mar 31, 2023 | 27.09B | 7.62B | 39.17% |
| Mar 31, 2022 | 19.46B | -1.10B | -5.35% |
| Mar 31, 2021 | 20.56B | 1.41B | 7.37% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 79.18B |
| Granules India | 50.92B |
| J. B. Chemicals & Pharmaceuticals | 41.93B |
| GlaxoSmithKline Pharmaceuticals | 38.01B |
| AstraZeneca Pharma India | 21.77B |
| Caplin Point Laboratories | 20.92B |
| Sanofi India | 18.37B |
| Viyash Scientific | 18.17B |
NATCO Pharma News
- 5 hours ago - Pharma sector stocks today, April 22: Natco Pharma up 1.4%, Lupin falls 1.01%, Cipla down 0.73% - Business Upturn
- 1 day ago - Pharma sector stocks today, April 21: Wockhardt surge 2.08%, Natco Pharma down 1.86%, Ajanta Pharma up 1.10% - Business Upturn
- 5 days ago - Pharma sector stocks today, April 17: Natco Pharma jumps 3.81%, Alembic Pharma up 2.14%, Strides Pharma rises 1.27% - Business Upturn
- 4 weeks ago - Pharma sector stocks today, March 25: Wockhardt surge 7.40%, Senores Pharma up 5.95%, Natco Pharma jumps 3.32% - Business Upturn
- 4 weeks ago - Pharma sector stocks rally sharply today, March 25: Wockhardt surge 7.40%, Senores Pharma up 5.95%, Natco Pharma jumps 3.32% - Business Upturn
- 4 weeks ago - Natco Pharma shares surge over 3% after board approves demerger of agrochemicals business - Business Upturn
- 4 weeks ago - Top Stocks For Trade Today, March 25: United Spirits, Sammaan Capital, Kotak Mahindra Bank, Natco Pharma, OMC, Paint Stocks - Business Upturn
- 4 weeks ago - Eris Lifesciences partners with Natco Pharma for semaglutide launch in India - Business Upturn